Latest News for: Pharmaceutical sources

Edit

FSD Pharma Announces Filing of Year-End 2022 Results

The Galveston Daily News 01 Apr 2023
FSD BioSciences, Inc., a wholly owned subsidiary, is focused on pharmaceutical research and development of its lead compound, FSD201, a proprietary ultra-micronized PEA formulation, for the treatment of inflammatory diseases ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005456/en/ ... SOURCE.
Edit

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The Galveston Daily News 01 Apr 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 31, 2023--. Sarepta Therapeutics, Inc ... The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4) ... About Sarepta Therapeutics ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005448/en/ ... FDA HEALTH RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY. SOURCE.
Edit

High Potency Active Pharmaceutical Ingredients Global Market Report 2023: Growth of Targeted Therapies and Rising ...

Eagle-Tribune 31 Mar 2023
The "High Potency Active Pharmaceutical Ingredients Market, by Product, by Manufacturer, by Drug, by Application, and by Region - Global Forecast to 2023-2033" report has been added to ResearchAndMarkets.com's offering ... High Potency Active Pharmaceutical Ingredients Market Report 2022 - 2033 ... High Potency Active Pharmaceutical Ingredients ... SOURCE.
Edit

Savara Announces New Employment Inducement Grant

The Galveston Daily News 31 Mar 2023
AUSTIN, Texas--(BUSINESS WIRE)--Mar 31, 2023--. Savara Inc. (Nasdaq ... About Savara ... www.linkedin.com/company/savara-pharmaceuticals/ ). View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005098/en/ ... BIOTECHNOLOGY PHARMACEUTICAL FINANCE GENERAL HEALTH HEALTH PROFESSIONAL SERVICES CLINICAL TRIALS OTHER HEALTH. SOURCE ... PUB.
Edit

Lipella Provides Business Update and Reports 2022 Financial Results

Longview News-Journal 31 Mar 2023
PITTSBURGH, March 31, 2023 /PRNewswire/ -- Lipella Pharmaceuticals Inc ... Jonathan Kaufman, Co-founder and CEO of Lipella Pharmaceuticals, commented, "Last year we focused on developing our corporate profile and scientific mission to address serious diseases with significant unmet need ... Lipella Pharmaceuticals Inc ... SOURCE Lipella Pharmaceuticals Inc.
Edit

CANbridge Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2022

The Galveston Daily News 31 Mar 2023
CANbridge Pharmaceuticals, Inc ... About CANbridge Pharmaceuticals Inc. CANbridge Pharmaceuticals Inc ... For more on CANbridge Pharmaceuticals Inc., please go to ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230330005789/en/ ... CANbridge Pharmaceuticals Inc ... HEALTH GENERAL HEALTH RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY.
Edit

AIS Healthcare Recognizes March as Multiple Sclerosis Awareness Month

The Joplin Globe 31 Mar 2023
DALLAS--(BUSINESS WIRE)--Mar 31, 2023--. AIS Healthcare is proud to recognize March as Multiple Sclerosis Awareness (MS) month ... About AIS Healthcare ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005433/en/. CONTACT ... MEDICAL SUPPLIES MEDICAL DEVICES HEALTH OTHER HEALTH GENERAL HEALTH PHARMACEUTICAL. SOURCE ... PUB ... .
Edit

Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days

The Galveston Daily News 31 Mar 2023
ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 31, 2023-- ... Genomic Medicines and Rare Disease Days, taking place from Monday, April 3 to Tuesday, April 4, 2023 in New York, NY ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005122/en/. CONTACT ... KEYWORD ... BIOTECHNOLOGY HEALTH GENETICS PHARMACEUTICAL CLINICAL TRIALS. SOURCE.
Edit

AIS Healthcare Celebrates Brain Injury Awareness Month

The Joplin Globe 31 Mar 2023
DALLAS--(BUSINESS WIRE)--Mar 31, 2023-- ... About AIS Healthcare. Advancing quality. Improving lives ... Learn more at aiscaregroup.com. View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005432/en/. CONTACT. Simon Castellanos ... OTHER CONSUMER HEALTH CONSUMER GENERAL HEALTH PHARMACEUTICAL PEOPLE WITH DISABILITIES. SOURCE ... PUB ... .
Edit

ABIONYX Pharma Announces Its Strategy in Ophthalmology and New Positive Preclinical Results for the Deployment ...

The Galveston Daily News 31 Mar 2023
TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Mar 31, 2023-- ... apotherapy and biovectorisation. Cyrille TUPIN, Chief Executive Officer of ABIONYX Pharma, said ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005400/en/ ... HEALTH CLINICAL TRIALS RESEARCH SCIENCE PHARMACEUTICAL OPTICAL BIOTECHNOLOGY. SOURCE.
Edit

Woman considered a ‘major player’ in Black Axe international crime gang questioned over €10m in bank accounts

Irish Independent 31 Mar 2023
“A total of around €10m is suspected to have gone through accounts linked to her, including almost €7m in her ‘business’ account.”Detectives have said the suspect has no significant trappings of wealth.Virtually all the cash that went ...
Edit

UF Health Jacksonville Honors 2023 Awardees for Patient Safety Efforts

The Galveston Daily News 31 Mar 2023
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Mar 30, 2023-- ... The award is named in honor of Robert L. Wears, M.D., MS, PhD, for his pioneering work to improve patient safety. Dr ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230330005823/en/ ... HEALTH HOSPITALS CLINICAL TRIALS GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY. SOURCE.
Edit

MedImpact Earns URAC Accreditation in Pharmacy Benefit Management

The Galveston Daily News 31 Mar 2023
SAN DIEGO--(BUSINESS WIRE)--Mar 31, 2023-- ... The three-year URAC accreditation for PBM covers 10 quality modules ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005080/en/ ... TECHNOLOGY MEDICAL SUPPLIES HOSPITALS TELEMEDICINE/VIRTUAL MEDICINE SOFTWARE BIOTECHNOLOGY HEALTH PHARMACEUTICAL GENERAL HEALTH. SOURCE ... PUB.
Edit

AriBio Co., Ltd. to Present Biomarker Data for AR1001 from the Mild to Moderate Alzheimer’s ...

The Galveston Daily News 31 Mar 2023
SAN DIEGO--(BUSINESS WIRE)--Mar 31, 2023--. AriBio Co., Ltd ... The trial enrolled 210 patients at 21 research centers in the United States ... Enrollment is expected to continue through 2024 ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005009/en/ ... BIOTECHNOLOGY NEUROLOGY MENTAL HEALTH HEALTH PHARMACEUTICAL. SOURCE.
Edit

Indiva to Report Fourth Quarter and Full Year Results Pre-Market on Tuesday April 18, 2023

The Galveston Daily News 31 Mar 2023
LONDON, Ontario--(BUSINESS WIRE)--Mar 31, 2023-- ... CONFERENCE CALL - Tuesday, April 18, 2023 at 8.30 a.m. (EDT). ... (EDT) ... The conference ID is 00296074 ... General ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230331005096/en/ ... ALTERNATIVE MEDICINE CANNABIS RETAIL HEALTH NATURAL RESOURCES PHARMACEUTICAL FOOD/BEVERAGE. SOURCE.

Most Viewed

In this photo provided by the Belarusian Presidential Press Service, Belarusian President Alexander Lukashenko delivers a state-of-the nation address in Minsk, Belarus, Friday, March 31, 2023
AP / Belarusian Presidential Press Service
European Commission President Ursula von der Leyen delivers her speech at the European Parliament, Wednesday, Oct. 19, 2022 in Strasbourg
AP / Jean-Francois Badias
File - Russian President Vladimir Putin, right, and North Korea's leader Kim Jong Un take an elevator heading to the talks in Vladivostok, Russia on April 25, 2019. As North Korea conducts more powerful weapons tests — and threatens pre-emptive nuclear strikes on Washington and Seoul — it may be taking inspiration from the fiery rhetoric of the leader of a nuclear-armed member of the U.N. Security Council: Russia's Vladimir Putin.
AP / Alexei Nikolsky/Sputnik, Kremlin/Pool Photo via AP, File
×